Multipl Miyelomlu Bir Hastada Tam Remisyon Sonrası Edinsel Hemofilinin Kaybolması

Kaynakça (11)

1. Reding MT. Immunological aspects of inhibitor development. Haemophilia 2006;(Suppl 6):30-35
2. Sakura Y, Takeda T. Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder. J Immunol Res 2014;2014:320674
3. Franchini M, Gandini G, Di Paolantonio T, Mariani G. Acquired hemophilia A: a concise review. Am J Hematol 2005;80:55-63
4. Sari I, Erkurt MA, Ifran A, Kaptan K, Beyan C. Multiple myeloma presenting with acquired factor VIII inhibitor. Int J Hematol 2009;90:166-169
5. Muzaffar J, Katragadda L, Haider S, Javed A, Anaissie E, Usmani S. Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature. Int J Hematol 2012;95:102-106
6. Ross C, Kuriakose K, Aswath GS, Subramanian S. Management of acquired haemophilia bleed in the backdrop of multiple myeloma. Indian J Hematol Blood Transfus 2015;31:151-153
7. Saburi M, Ohtsuka E, Itani K, Nagamatsu K, Ikebe T, Miyazaki Y, Ogata M, Saburi Y. Development of acquired hemophilia A during treatment of multiple myeloma with lenalidomide. Rinsho Ketsueki 2015;56:496-500
8. Dunn AL. Malignancy in patients with hemophilia: a review of the literature. Haemophilia 2010;16:427-436
9. Lesley R, Xu Y, Kalled SL, Hess DM, Schwab SR, Shu HB, Cyster JG. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 2004;4:441-453
10. Pavlova A, Zeitler H, Scharrer I, Brackmann HH, Oldenburg J. HLA genotype in patients with acquired haemophilia A. Haemophilia 2010;16:107-112
11. Sallah S, Wan JY. Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients. Cancer 2001;91:1067-1074.